These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34668453)

  • 1. Compound heterozygous P67S/D91A
    De La Cruz E; Guissart C; Esselin F; Polge A; Pageot N; Taieb G; Lumbroso S; Camu W; Mouzat K
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug; 23(5-6):458-461. PubMed ID: 34668453
    [No Abstract]   [Full Text] [Related]  

  • 2. Individual Oligogenic Background in p.D91A-
    Gentile G; Perrone B; Morello G; Simone IL; Andò S; Cavallaro S; Conforti FL
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of
    Yilmaz R; Grehl T; Eckrich L; Marschalkowski I; Weishaupt K; Valkadinov I; Simic M; Brenner D; Andersen PM; Wolf J; Weishaupt JH
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 Aug; 24(5-6):414-419. PubMed ID: 36650645
    [No Abstract]   [Full Text] [Related]  

  • 4. Heterozygous D90A-SOD1 mutation in a patient with facial onset sensory motor neuronopathy (FOSMN) syndrome: a bridge to amyotrophic lateral sclerosis.
    Dalla Bella E; Rigamonti A; Mantero V; Morbin M; Saccucci S; Gellera C; Mora G; Lauria G
    J Neurol Neurosurg Psychiatry; 2014 Sep; 85(9):1009-11. PubMed ID: 24591457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOD1 D91A variant in the southernmost tip of Europe: a heterozygous ALS patient resident on the island of Gozo.
    Farrugia Wismayer M; Farrugia Wismayer A; Pace A; Vassallo N; Cauchi RJ
    Eur J Hum Genet; 2022 Jul; 30(7):856-859. PubMed ID: 34616013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characterization of common pathogenic variants of SOD1-ALS in Germany.
    Wiesenfarth M; Forouhideh-Wiesenfarth Y; Elmas Z; Parlak Ö; Weiland U; Herrmann C; Schuster J; Freischmidt A; Müller K; Siebert R; Günther K; Fröhlich E; Knehr A; Simak T; Bachhuber F; Regensburger M; Petri S; Klopstock T; Reilich P; Schöberl F; Schumann P; Körtvélyessy P; Meyer T; Ruf WP; Witzel S; Tumani H; Brenner D; Dorst J; Ludolph AC
    J Neurol; 2024 Oct; 271(10):6667-6679. PubMed ID: 39141064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facial onset amyotrophic lateral sclerosis with K3E variant in the Cu/Zn superoxide dismutase gene.
    Shibuya K; Sawai S; Sugiyama A; Koide M; Nishiyama A; Aoki M; Kuwabara S
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Feb; 22(1-2):144-146. PubMed ID: 32729725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel p.E121G heterozygous missense mutation of SOD1 in an apparently sporadic ALS case with a 14-year course.
    Canosa A; Calvo A; Moglia C; Barberis M; Brunetti M; Cammarosano S; Manera U; Ilardi A; Restagno G; Chiò A
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):127-8. PubMed ID: 25299943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tofersen decreases neurofilament levels supporting the pathogenesis of the SOD1 p.D91A variant in amyotrophic lateral sclerosis patients.
    Weishaupt JH; Körtvélyessy P; Schumann P; Valkadinov I; Weyen U; Hesebeck-Brinckmann J; Weishaupt K; Endres M; Andersen PM; Regensburger M; Dreger M; Koch JC; Conrad J; Meyer T
    Commun Med (Lond); 2024 Jul; 4(1):150. PubMed ID: 39054363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel p.N66T mutation in exon 3 of the SOD1 gene: report of two families of ALS patients with early cognitive impairment.
    Martinelli I; Zucchi E; Gessani A; Fini N; Chiò A; Pecoraro V; Trenti T; Mandrioli J
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 May; 21(3-4):296-300. PubMed ID: 32248719
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
    Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
    Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis.
    Robberecht W; Aguirre T; Van den Bosch L; Tilkin P; Cassiman JJ; Matthijs G
    Neurology; 1996 Nov; 47(5):1336-9. PubMed ID: 8909456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALS with variable phenotypes in a six-generation family caused by leu144phe mutation in the SOD1 gene.
    Masè G; Ros S; Gemma A; Bonfigli L; Carraro N; Cazzato G; Rolfo M; Zanconati F; Sepcic J; Jurjevic A; Pirulli D; Boniotto M; Zezlina S; Crovella S; Amoroso A
    J Neurol Sci; 2001 Oct; 191(1-2):11-8. PubMed ID: 11676987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial amyotrophic lateral sclerosis with a novel G85S mutation of superoxide dismutase 1 gene: clinical features of lower motor neuron disease.
    Takazawa T; Ikeda K; Hirayama T; Kawabe K; Nakamura Y; Ito H; Kano O; Yoshii Y; Tanaka F; Sobue G; Iwasaki Y
    Intern Med; 2010; 49(2):183-6. PubMed ID: 20075587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the Cu/Zn superoxide dismutase gene in a Catalan ALS population: should all sporadic ALS cases also be screened for SOD1?
    Gamez J; Corbera-Bellalta M; Nogales G; Raguer N; García-Arumí E; Badia-Canto M; Lladó-Carbó E; Alvarez-Sabín J
    J Neurol Sci; 2006 Aug; 247(1):21-8. PubMed ID: 16674979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clustering of ALS patients in central Italy due to the occurrence of the L84F SOD1 gene mutation.
    Ceroni M; Malaspina A; Poloni TE; Alimonti D; Rognoni F; Habgood J; Imbesi F; Antonelli P; Alfonsi E; Curti D; deBelleroche J
    Neurology; 1999 Sep; 53(5):1064-71. PubMed ID: 10496267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The G41D mutation in SOD1-related amyotrophic lateral sclerosis exhibits phenotypic heterogeneity among individuals: A case report and literature review.
    Zhao X; Feng X; Li X; Mou J; Liu H; Chen J; Wu J
    Medicine (Baltimore); 2022 Feb; 101(6):e28771. PubMed ID: 35147103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four familial ALS pedigrees discordant for two SOD1 mutations: are all SOD1 mutations pathogenic?
    Felbecker A; Camu W; Valdmanis PN; Sperfeld AD; Waibel S; Steinbach P; Rouleau GA; Ludolph AC; Andersen PM
    J Neurol Neurosurg Psychiatry; 2010 May; 81(5):572-7. PubMed ID: 20460594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOD1 (A4V)-mediated ALS presenting with lower motor neuron facial diplegia and unilateral vocal cord paralysis.
    Salameh JS; Atassi N; David WS
    Muscle Nerve; 2009 Nov; 40(5):880-2. PubMed ID: 19618436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterozygous SOD1 D90A mutation presenting as slowly progressive predominant upper motor neuron amyotrophic lateral sclerosis.
    Luigetti M; Conte A; Madia F; Marangi G; Zollino M; Mancuso I; Dileone M; Del Grande A; Di Lazzaro V; Tonali PA; Sabatelli M
    Neurol Sci; 2009 Dec; 30(6):517-20. PubMed ID: 19685200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.